Oral Azithromycin for Treatment of Intractable Rosacea.
10.3346/jkms.2011.26.5.694
- Author:
Jae Hong KIM
1
;
Yoon Seok OH
;
Eung Ho CHOI
Author Information
1. Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea. choieh@yonsei.ac.kr
- Publication Type:Case Report
- Keywords:
Azithromycin;
Rosacea
- MeSH:
Administration, Oral;
Azithromycin/administration & dosage/pharmacology/*therapeutic use;
Erythema/diagnosis/drug therapy;
Female;
Humans;
Middle Aged;
Reactive Oxygen Species;
Rosacea/diagnosis/*drug therapy;
Skin Diseases/drug therapy
- From:Journal of Korean Medical Science
2011;26(5):694-696
- CountryRepublic of Korea
- Language:English
-
Abstract:
Rosacea is a common chronic cutaneous disorder that primarily occurs on the convex surfaces of the central face and is often characterized by exacerbations and remissions. A case of a 52-yr-old woman visited our clinic in February 2008 complaining typical features of rosacea including multiple pinhead to rice-sized erythematous papules. We applied various conventional treatments including topical benzoyl peroxide and metronidazole as well as oral metronidazole, isotretinoin, and doxycycline. The lesions were not controlled but were rather aggravated by complications from these treatments. Therefore, we prescribed oral azithromycin, which has anti-inflammatory effects and reduces reactive oxygen species. Ten weeks after the administration of oral azithromycin, 500 mg per day for 2 weeks, the lesions had mostly disappeared and no specific side effects related to the azithromycin were noted. Oral azithromycin dosing 500 mg/day for 2 weeks is effective for treatment of intractable rosacea.
